Artificial Lumbar Disc Trial Results Could Make SpineCore Acquisition Target
This article was originally published in The Gray Sheet
Executive Summary
SpineCore will begin a randomized, multi-site U.S. clinical trial for its FlexiCore intervertebral disc this month under a July 25 FDA investigational device exemption